Biznesradar bez reklam? Sprawdź BR Plus
Wiadomości INC
1.500+0.060(+4.17%)INC SPÓŁKA AKCYJNA
GPW - Akcje/PDA - Notowania ciągłe
Biznesradar bez reklam? Sprawdź BR Plus
Galectin Therapeutics Inc.
The post Galectin Therapeutics Releases Q2 2026 Financial Results first appeared on Alphastreet.
Annovis Bio, Inc.
The post Annovis Bio Releases Q2 2026 Financial Results first appeared on Alphastreet.
Quince Therapeutics, Inc.
The post Quince Therapeutics Releases Q2 2026 Financial Results first appeared on Alphastreet.
VerifyMe, Inc.
The post VerifyMe Releases Q2 2026 Financial Results first appeared on Alphastreet.
CSP Inc.
The post Csp Releases Q3 2026 Financial Results first appeared on Alphastreet.
PMV Pharmaceuticals, Inc.
The post PMV Pharmaceuticals Releases Q2 2026 Financial Results first appeared on Alphastreet.
Wall Street expects modest growth. The Estée Lauder Companies Inc. (NYSE:EL) reports fourth-quarter fiscal 2026 results on August 19 before market open, wit...
The post Estée Lauder Companies (EL) Q4 2026 Preview: EPS Est. $0.32, Reports August 19 first appeared on Alphastreet.
Wall Street is bracing for a sharp year-over-year decline when Toll Brothers, Inc. (NYSE:TOL) reports fiscal third-quarter 2026 results before market open on...
The post Toll Brothers Q3 2026 Earnings Preview — August 19, Street Expects $2.93 EPS first appeared on Alphastreet.
SurgePays, Inc.
The post SurgePays Releases Q2 2026 Financial Results first appeared on Alphastreet.
Lantern Pharma Inc.
The post Lantern Pharma Releases Q2 2026 Financial Results first appeared on Alphastreet.
Tvardi Therapeutics, Inc.
The post Tvardi Therapeutics Releases Q2 2026 Financial Results first appeared on Alphastreet.
Gemini Space Station, Inc.
The post Gemini Space Station Releases Q2 2026 Financial Results first appeared on Alphastreet.
Lument Finance Trust, Inc.
The post Lument Finance Trust Releases Q2 2026 Financial Results first appeared on Alphastreet.
Neumora Therapeutics, Inc.
The post Neumora Therapeutics Releases Q2 2026 Financial Results first appeared on Alphastreet.
Rein Therapeutics Inc.
The post Rein Therapeutics Releases Q2 2026 Financial Results first appeared on Alphastreet.
Wall Street expects a robust profit increase when Analog Devices, Inc. (NASDAQ:ADI) reports third-quarter fiscal 2026 results on August 19 during market hour...
The post Analog Devices Q3 2026 Earnings Preview — August 19, Street Expects $2.93 EPS first appeared on Alphastreet.
RLX Technology Inc.
The post RLX Technology Releases Q2 2026 Financial Results first appeared on Alphastreet.
Applied Materials, Inc.
The post Applied Materials Releases Q3 2026 Financial Results first appeared on Alphastreet.
Smith Micro Software, Inc.
The post Smith Micro Software Releases Q2 2026 Financial Results first appeared on Alphastreet.
Applied Materials, Inc. (NASDAQ: AMAT) reported a sharp increase in revenues and adjusted earnings for the third quarter of fiscal...
The post Applied Materials (AMAT) Q3 FY26 earnings jump on record high revenues first appeared on Alphastreet.
Biznesradar bez reklam? Sprawdź BR Plus
Biznesradar bez reklam? Sprawdź BR Plus
Informacje
| ISIN: | PLINCLT00015 |
|---|---|
| Data debiutu: | 09.08.2006 |
| Liczba akcji: | 15 043 099 |
| Kapitalizacja: | 22 564 649 |
| Enterprise Value: | 22 177 649 |
| Branża: | Działalność inwestycyjna |
INC funkcjonuje w obszarze inwestycji oraz doradztwa na rynku kapitałowym. Spółka specjalizuje się w pomocy i wsparciu małym i średnim spółkom... INC funkcjonuje w obszarze inwestycji oraz doradztwa na rynku kapitałowym. Spółka specjalizuje się w pomocy i wsparciu małym i średnim spółkom działającym w różnych sektorach. Poza prywatnymi przedsiębiorstwami, INC świadczy również usługi doradcze jednostkom samorządu terytorialnego oraz angażuje się w projekty sportowe, kulturalne i akademickie.
| Nazwa: | INC SPÓŁKA AKCYJNA |
|---|---|
| Adres: | ul. Abpa Antoniego Baraniaka 6, 61-131, Poznań, Polska |
| CEO: | Paweł Śliwiński |
| NIP: | 7781024498 |
| REGON: | 630316445 |
| KRS: | 0000028098 |
| WWW: | http://www.incsa.pl/ |
Biznesradar bez reklam? Sprawdź BR Plus

